Key facts
- It has raised $15.7M; the latest was Later Stage VC in Jul 2025.
- Notable investors include CMG SDIC Fund, GL Capital Group, Liaoning Sansheng Private Equity Fund Management, Tofflon Science and Technology Group.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for LEATECK
- ·The full record, as it builds
Funding rounds
No funding rounds for LEATECK are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LEATECK
Provider of intelligent and digital solutions intended for pharmaceutical businesses. The company offers smart solutions, digital factory, manufacturing execution system (MES), current good manufacturing practices, and quality review system, enabling pharmaceutical businesses to improve work efficiency.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2014
- Website
- leateckgroup.com/
- Ownership
- Privately Held (backing)
LEATECK doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LEATECK shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LEATECK in its N-PORT filings yet. We sweep new filings monthly.